Mayo Clinic Platform launches AI decision support across more than 35 specialties

Mayo Clinic Platform, the commercial and innovation arm of Mayo Clinic, has released an AI clinical decision support tool that pulls a patient's record and relevant clinical evidence into the consultation, the health system said in an announcement reported on 5 November 2026¹. The tool gives specialty-specific guidance in more than 35 specialties¹.

What the tool does

The core of the product is a chatbot built on Mayo Clinic's own medical knowledge base. Clinicians can put clinical questions to it, work through possible diagnoses and compare care options, and ask it to search the medical literature¹. Mayo Clinic said the tool can sit inside several electronic health records, so that the answers draw on the patient's own data and feed into individual care plans¹.

It also bundles 22 clinical calculators covering areas such as cardiology, oncology, hepatology and endocrinology, which apply scoring systems and formulas to a patient's data to produce care recommendations¹. Clinicians can drive the calculators by typed message or by voice dictation¹. Mayo Clinic said clinicians took part in building the tool, testing it and giving feedback during development¹.

Access is limited. The product is open to Mayo Clinic's own clinicians and to staff at organisations that take part in Mayo Clinic Platform's provider programmes¹. Maneesh Goyal, chief operating officer of Mayo Clinic Platform, said that "finding relevant information for individualized patient care takes valuable time"¹.

What it means for the market

Clinical decision support is among the most common uses of AI in health systems, and the start-ups selling such tools have raised hundreds of millions of dollars from investors¹. Mayo Clinic's entry changes the competitive picture for those vendors in one specific way: a large academic health system is now offering its own branded knowledge, rather than a third-party model, to the organisations in its network¹. For a CMIO choosing between suppliers, the question becomes whether a provider-built tool tied to one institution's guidance is preferable to an independent product.

The launch fits a pattern of AI investment at Mayo Clinic, which announced a partnership with Microsoft in June to build an AI model dedicated to healthcare¹. The announcement does not say whether that model underpins the new tool.

Several things a buyer would want to know are missing from the announcement. It gives no price, no count of participating organisations or clinicians, and no list of the electronic health records it integrates with beyond "several"¹. It reports no accuracy figures, safety evaluation or regulatory status, and the only testing described is the feedback from clinicians who helped design it¹. Until Mayo Clinic Platform publishes evidence on how the tool performs in practice, health systems in its programmes will be judging it on the institution's reputation rather than on outcome data.